Bradley J Phd Bolzon's Net Worth
$154 Million
Who is Bradley J Phd Bolzon?
Bradley J Phd Bolzon has an estimated net worth of $154 Million. This is based on reported shares across multiple companies, which include Inogen Inc, SECOND SIGHT MEDICAL PRODUCTS INC, HELICOS BIOSCIENCES CORP, Alexza Pharmaceuticals Inc., Flexion Therapeutics Inc, Monte Rosa Therapeutics, Inc., CRISPR Therapeutics AG, Black Diamond Therapeutics, Inc., NOVACEA INC, and PHASERX, INC..
SEC CIK
Bradley J Phd Bolzon's CIK is 0001354345
Past Insider Trading and Trends
2020 was Bradley J Phd Bolzon's most active year for acquiring shares with 75 total transactions. Bradley J Phd Bolzon's most active month to acquire stocks was the month of October. 2020 was Bradley J Phd Bolzon's most active year for disposing of shares, totalling 191 transactions. Bradley J Phd Bolzon's most active month to dispose stocks was the month of October. 2016 saw Bradley J Phd Bolzon paying a total of $15,253,990.00 for 8,043,984 shares, this is the most they've acquired in one year. In 2021 Bradley J Phd Bolzon cashed out on 33,061,115 shares for a total of $43,786,895.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alexza Pharmaceuticals Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.18M |
—
|
—
| 2.18M |
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Flexion Therapeutics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.35% | 714.28K |
$14.00 | $9,999,990.00 | 3.53M |
Jun 8
| |||
Form 4
|
∞
| 2.25K |
$17.61 | $39,622.50 | 2.25K |
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| +2,931.58% | 3.1M |
$13.00 |
—
| 3.21M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $4.67
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3,041.10% | 8.61M |
$19.00 |
—
| 8.9M |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24 - Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CRISPR Therapeutics AG (CRSP) Snapshot price: $66.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| -6.30% | -10.00K |
$126.43 | -$1,264,347.53 | 148.83K |
Scheduled
|
Jul 19
| ||
Form 4
| -67.01% | -1.04M |
$149.49 | -$7,106,341.02 | 510.25K |
Scheduled
|
Jun 28 - Jun 29
| ||
Form 4
| -16.05% | -30.38K |
$152.48 | -$4,631,582.53 | 158.83K |
Scheduled
|
Jun 28
| ||
Form 4
| -32.92% | -10.00K |
$126.61 | -$1,266,118.41 | 20.38K |
Scheduled
|
Jun 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| -50.00% | -30.37K |
$132.37 | -$4,020,666.79 | 30.38K |
Scheduled
|
Mar 22
| ||
Form 4
| -24.21% | -264.88K |
—
|
—
| 829.14K |
Scheduled
|
Mar 1
| ||
Form 4
| -36.23% | -1.16M |
$149.11 | -$25,497,839.62 | 2.04M |
Feb 19
| |||
Form 4
| -4.23% | -15.00K |
$148.95 | -$2,234,265.51 | 339.83K |
Scheduled
|
Dec 16
| ||
Form 4/A
| -81.18% | -33.00K |
$143.35 | -$4,730,447.90 | 7.65K |
Scheduled
|
Dec 10
| ||
Form 4
| -9.50% | -33.00K |
$143.35 | -$4,730,447.90 | 314.19K |
Scheduled
|
Dec 10
| ||
Form 4
| -33.00% | -171.00K |
$154.53 | -$26,424,505.04 | 347.19K |
Dec 7
| |||
Form 4
| -22.17% | -394.36K |
—
|
—
| 1.38M |
Scheduled
|
Oct 29
| ||
Form 4
| -15.06% | -315.49K |
—
|
—
| 1.78M |
Scheduled
|
Sep 22
| ||
Form 4
| -0.58% | -3.04K |
$86.87 | -$263,635.88 | 518.19K |
Scheduled
|
Sep 18
| ||
Form 4
| -1.69% | -8.96K |
$86.98 | -$779,777.49 | 521.23K |
Scheduled
|
Sep 16
| ||
Form 4
| -0.22% | -1.16K |
$84.89 | -$98,045.29 | 530.19K |
Scheduled
|
Sep 14
| ||
Form 4
| -6.43% | -180.59K |
$85.36 | -$1,949,996.35 | 2.63M |
Scheduled
|
Sep 9 - Sep 10
| ||
Form 4
|
—
|
0
|
$58.87 | -$4,036,694.20 |
0
|
Sep 1
| |||
Form 4
| -3.48% | -20.00K |
$82.39 | -$1,647,730.03 | 554.19K |
Scheduled
|
Jul 6
| ||
Form 4
| -3.37% | -20.00K |
$73.93 | -$1,478,522.00 | 574.19K |
Scheduled
|
Jun 22 - Jun 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| -6.58% | -42.00K |
$67.41 | -$2,831,388.00 | 596.74K |
Scheduled
|
Nov 19
| ||
Form 4
| -60.44% | -21.00K |
$51.89 | -$1,089,675.30 | 13.74K |
Scheduled
|
Oct 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| -6.43% | -44.00K |
$57.99 | -$2,551,440.00 | 640.01K |
May 15
| |||
Form 4
| -4.47% | -128.95K |
$50.76 | -$6,497,892.30 | 2.76M |
Scheduled
|
May 7 - May 8
| ||
Form 4
| -2.03% | -30.57K |
$50.28 | -$1,537,137.92 | 1.48M |
Scheduled
|
Apr 30
| ||
Form 4
| -6.84% | -222.26K |
$50.08 | -$11,136,437.01 | 3.03M |
Scheduled
|
Apr 26 - Apr 27
| ||
Form 4
| -1.30% | -22.84K |
$50.90 | -$1,164,655.40 | 1.73M |
Scheduled
|
Apr 24
| ||
Form 4
| -12.64% | -585.73K |
$50.83 | -$5,168,901.34 | 4.05M |
Scheduled
|
Apr 20 - Apr 23
| ||
Form 4
| -48.41% | -26.02K |
$20.30 | -$528,236.67 | 27.72K |
Scheduled
|
Dec 22
| ||
Form 4
| -3.08% | -1.71K |
$20.21 | -$34,498.44 | 53.74K |
Scheduled
|
Nov 24 - Nov 27
| ||
Form 4
| -32.53% | -2.25M |
—
|
—
| 4.66M |
Sep 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +2,783.12% | 6.67M |
$14.00 |
—
| 6.91M |
Oct 18 - Oct 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inogen Inc (INGN) Snapshot price: $7.535
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -11.28% | -384.69K |
$24.30 | -$179,534.67 | 3.03M |
Nov 5 - Nov 7
| |||
Form 4
| -35.10% | -735.77K |
—
|
—
| 1.36M |
Jan 6 - Jan 7
| |||
Form 4
| -100.00% | -7.95K |
$30.98 | -$246,159.13 |
0
|
Jan 5
| |||
Form 4/A
| -18.22% | -478.05K |
—
|
—
| 2.15M |
Dec 18
| |||
Form 4
| -100.00% | -9.79K |
$29.74 | -$291,008.84 |
0
|
Dec 23
| |||
Form 4
| -18.22% | -478.05K |
—
|
—
| 2.15M |
Dec 18
| |||
Form 4
| -41.03% | -28.23K |
$24.80 | -$699,253.17 | 40.57K |
Nov 17 - Nov 19
| |||
Form 4
| -22.13% | -753.69K |
$25.13 | -$237,086.41 | 2.65M |
Nov 12 - Nov 14
| |||
Form 4
| -100.00% | -8.64K |
$24.53 | -$211,691.35 |
0
|
Nov 10
| |||
Form 4
| +4.31% | 4.44K |
$24.30 | -$179,534.67 | 107.47K |
Nov 5 - Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -77.05% | -51.70K |
—
|
—
| 15.4K |
Oct 7
| |||
| No matching records found | |||||||||